Skip to main content
. 2022 Aug 2;10(8):1238. doi: 10.3390/vaccines10081238

Figure 3.

Figure 3

Number of solicited side effects after the second vaccine dose in the study population after case–control matching. Number of side effects reported for SARS-CoV-2 naïve (gray) and previously infected subjects (magenta; p = 0.133 by Chi-squared test).